Cytogenetic abnormalities in essential thrombocythemia at presentation and transformation (Q34405385)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Cytogenetic abnormalities in essential thrombocythemia at presentation and transformation	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19728024

retrieved

2 August 2017

title

Cytogenetic abnormalities in essential thrombocythemia at presentation and transformation (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19728024

retrieved

2 August 2017

author

Hagop Kantarjian

series ordinal

2

object named as

Hagop Kantarjian

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19728024

retrieved

2 August 2017

Zeev Estrov

series ordinal

5

object named as

Zeev Estrov

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19728024

retrieved

2 August 2017

Srdan Verstovsek

series ordinal

7

object named as

Srdan Verstovsek

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19728024

retrieved

2 August 2017

Jorge Eduardo Cortes

series ordinal

6

object named as

Jorge Cortes

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19728024

retrieved

2 August 2017

Sherry Pierce

series ordinal

3

object named as

Sherry Pierce

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19728024

retrieved

2 August 2017

Matjaž Sever

series ordinal

1

object named as

Matjaz Sever

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19728024

retrieved

2 August 2017

author name string

Nitin Jain

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19728024

retrieved

2 August 2017

language of work or name

English

1 reference

based on heuristic

inferred from title

publication date

29 August 2009

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19728024

retrieved

2 August 2017

published in

International Journal of Hematology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19728024

retrieved

2 August 2017

volume

90

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19728024

retrieved

2 August 2017

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19728024

retrieved

2 August 2017

page(s)

522-525

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19728024

retrieved

2 August 2017

cites work

Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209590

retrieved

6 July 2018

Long-term outcome of 231 patients with essential thrombocythemia: prognostic factors for thrombosis, bleeding, myelofibrosis, and leukemia

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209590

retrieved

6 July 2018

The World Health Organization (WHO) classification of the myeloid neoplasms

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209590

retrieved

6 July 2018

Cytogenetic and molecular genetic aspects of essential thrombocythemia

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209590

retrieved

6 July 2018

Acquired pericentric inversion of chromosome 9 in acute myeloid leukemia.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS12185-009-0411-5

retrieved

21 January 2018

Cytogenetic abnormalities in essential thrombocythemia: prevalence and prognostic significance

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209590

retrieved

27 October 2018

Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209590

retrieved

27 October 2018

Single chromosomal abnormalities in Philadelphia-negative chronic myeloproliferative disorders.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209590

retrieved

27 October 2018

The gain-of-function JAK2 V617F mutation shifts the phenotype of essential thrombocythemia and chronic idiopathic myelofibrosis to more "erythremic" and less "thrombocythemic": a molecular, histologic, and clinical study.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209590

retrieved

27 October 2018

Correlations of JAK2-V617F mutation with clinical and laboratory findings in patients with myeloproliferative disorders.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209590

retrieved

27 October 2018

Acquired inv(9): what is its significance?

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209590

retrieved

27 October 2018

Conventional cytogenetics of myeloproliferative diseases other than CML contribute valid information.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209590

retrieved

27 October 2018

5q- syndrome presenting chronic myeloproliferative disorders-like manifestation: a case report

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728024

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytogenetic analysis in essential thrombocythemia at diagnosis and at transformation. A 12-year study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728024

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Deletion of the long arm of chromosome 5 in essential thrombocythemia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728024

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

5q--in essential thrombocythemia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728024

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

5q-syndrome presenting as essential thrombocythemia: myelodysplastic syndrome or chronic myeloproliferative disorders?

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728024

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

De novo appearance of der(1;7)(q10;p10) is associated with leukemic transformation and unfavorable prognosis in essential thrombocythemia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728024

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728024

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validation of two clinically useful assays for evaluation of JAK2 V617F mutation in chronic myeloproliferative disorders

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728024

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytogenetic findings in untreated patients with essential thrombocythemia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728024

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

JAK2V617F mutation in platelets from essential thrombocythemia patients: correlation with clinical features and analysis of STAT5 phosphorylation status

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728024

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk stratification for survival and leukemic transformation in essential thrombocythemia: a single institutional study of 605 patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728024

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Unbalanced translocation der(1;7)(q10;p10) defines a unique clinicopathological subgroup of myeloid neoplasms

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728024

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

JAK2(V617F) mutational status as determined by semiquantitative sequence-specific primer-single molecule fluorescence detection assay is linked to clinical features in chronic myeloproliferative disorders

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728024

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728024

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

20+ yr without leukemic or fibrotic transformation in essential thrombocythemia or polycythemia vera: predictors at diagnosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728024

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acquired pericentric inversion of chromosome 9 in essential thrombocythemia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19728024

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S12185-009-0411-5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19728024

retrieved

2 August 2017

Dimensions Publication ID

1046593653

0 references

ORKG ID

R32974

0 references

PMC publication ID

4209590

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19728024

retrieved

2 August 2017

PubMed publication ID

19728024

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19728024

retrieved

2 August 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34405385&oldid=2196592793"